CCRM
Andrea McRae is an accomplished project manager with extensive experience in scientific research and development, currently serving at CCRM since April 2022. Previously, Andrea held the role of Project Manager of R&D at VBI Vaccines Inc., where leadership included managing preclinical development programs and coordinating cross-functional teams. Prior experience includes a position as Research Project Officer at the Ottawa Hospital Research Institute, where responsibilities encompassed program development and grant administration. Andrea also contributed to various academic settings as a speaker and presenter, showcasing research in cellular and molecular biology. Academic credentials include a Master of Science in Cellular and Molecular Medicine from the University of Ottawa and a Bachelor of Arts in Cell/Cellular and Molecular Biology from Connecticut College.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.